SenesTech, Inc. (SNES) [Rocket]

Overview

SenesTech, Inc. (SNES)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/06/2023	S-3	Form S-3 - Registration statement under Securities Act of 1933:
09/26/2023	S-8	Form S-8 - Securities to be offered to employees in employee benefit plans:
08/22/2023	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
08/21/2023	8-K	Submission of Matters to a Vote of Security Holders  Interactive Data
08/10/2023	8-K	Quarterly results
07/31/2023	DEF 14A	Form DEF 14A - Other definitive proxy statements:
07/21/2023	S-1	Form S-1 - General form for registration of securities under the Securities Act of 1933:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
Revenues	1.0	0.6	0.3	0.1	0.3	0.1	0.3	0.2
Revenue growth	69.8%	112.8%	97.2%	-51.9%	471.2%	-83.6%	32.0%	-85.1%
Cost of goods sold	0.6	0.4	0.3	0.1	0.2	0.0	0.0	0.0
Gross profit	0.5	0.2	0.0	0.0	0.1	0.0	0.3	0.2
Gross margin	45.5%	40.7%	0.4%	29.4%	18.9%	13.5%	100.0%	100.0%
Selling, general and administrative	8.3
Research and development	1.9	2.0	1.5	1.9	2.4	3.2	2.7	7.2
General and administrative		7.2	6.4	8.4	9.5	9.1	8.1	8.7
EBIT	-9.7	-8.9	-7.9	-10.3	-11.9	-12.3	-10.5	-15.6
EBIT margin	-949.4%	-1489.0%	-2813.1%	-7193.7%	-4000.0%	-23684.6%	-3306.9%	-6491.7%
Pre-tax income	-9.7	-8.3	-8.4	-10.0	-11.9	-12.3	-10.8	-18.2
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-9.7	-8.3	-8.4	-10.0	-12.2	-12.3	-11.0	-18.2
Net margin	-951.4%	-1378.0%	-2969.1%	-7013.3%	-4121.5%	-23626.9%	-3444.7%	-7547.7%

Diluted EPS	($15.50)	($0.74)	($2.78)	($7.69)	($12.62)	($1.12)	($1.71)	($4.72)
Shares outstanding (diluted)	0.6	11.2	3.0	1.3	1.0	10.9	6.4	3.9

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.